Loading clinical trials...
Loading clinical trials...
To evaluate the long-term safety of pregabalin in refractory partial epilepsy.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT00280059 · Epilepsy, Partial
NCT00113165 · Epilepsy, Epilepsy, Partial
NCT01457989 · Epilepsy, Partial
Pfizer Investigational Site
Little Rock, Arkansas
Pfizer Investigational Site
Los Angeles, California
Pfizer Investigational Site
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions